deflazacort

FDA Drug Profile — EMFLAZA, DEFLAZACORT, Deflazacort, PYQUVI

deflazacort is listed in the FDA National Drug Code directory with 15 NDC codes, marketed under brand names including EMFLAZA, DEFLAZACORT, Deflazacort. Available dosage forms: tablet, suspension.

Drug details

Generic Name
deflazacort
Brand Names
EMFLAZA, DEFLAZACORT, Deflazacort, PYQUVI
Application Number
NDA208684
Sponsor
PTC Therapeutics, Inc.
NDC Codes
15
Dosage Forms
TABLET, SUSPENSION
Routes
ORAL
Active Ingredients
DEFLAZACORT

Indications and Usage

1 INDICATIONS AND USAGE JAYTHARI is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older. JAYTHARI is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.